Skip to Content

Franklin International Equity C LMGEX

Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 18.33  /  +0.44 %
  • Total Assets 291.7 Mil
  • Adj. Expense Ratio
    2.050%
  • Expense Ratio 2.050%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 1.39%
  • Turnover 34%

USD | NAV as of Jun 20, 2024 | 1-Day Return as of Jun 20, 2024, 10:18 PM GMT+0

Morningstar’s Analysis LMGEX

Will LMGEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Franklin International Equity C's Average People Pillar and Process Pillar ratings are n't enough to prevent other weaknesses from sending this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LMGEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.08 7.1 Mil
Healthcare

ASML Holding NV

2.65 6.1 Mil
Technology

Invesco Shrt-Trm Inv Treasury Instl

1.80 4.2 Mil
Cash and Equivalents

Novartis AG Registered Shares

1.51 3.5 Mil
Healthcare

Nestle SA

1.17 2.7 Mil
Consumer Defensive

Allianz SE

1.13 2.6 Mil
Financial Services

Toyota Motor Corp

1.07 2.5 Mil
Consumer Cyclical

Siemens AG

1.07 2.5 Mil
Industrials

Shin-Etsu Chemical Co Ltd

1.06 2.5 Mil
Basic Materials

Roche Holding AG

1.05 2.4 Mil
Healthcare